After hip replacement surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age between 50 and 80 years old ; (2) Planning to undergo the first unilateral total hip arthroplasty (THA), and the surgical approach is direct anterior approach (DAA); (3) Undergoing general anesthesia or intraspinal anesthesia; (4) American Society of Anesthesiologists (ASA) classification is grade I, II, or III; (5) Complicated with diabetes, and the blood sugar control was stable before enrollment (glycated hemoglobin HbA1c = 8.0%); (6) At 2 hours after surgery, moderate or higher pain occurred at rest (visual analogue score = 4 points); (7) Clear consciousness, normal awareness, and able to communicate effectively with researchers; (8) Voluntarily participate in this study and sign the written informed consent form; (9) Good compliance, willing and able to cooperate with all intervention treatments and follow-up evaluations.
Exclusion criteria
Exclusion criteria: (1) Patients with diabetes whose blood sugar levels are poorly controlled and who have severe complications; (2) Patients with skin damage, infection, or ulcers in the surgical area; (3) Patients with a bleeding tendency or abnormal coagulation function (defined as: international normalized ratio > 1.5 during screening, or platelet count <eighty times ten to the ninth power/L, or inability to discontinue anticoagulant/antiplatelet drugs as per routine before surgery); (4) Patients with other chronic pain histories other than hip joint pain (such as severe lumbar disc herniation, severe arthritis, etc.) before surgery, and those who have been using analgesics regularly within 1 month before surgery which may interfere with postoperative pain assessment; (5) Patients with a history of opioid use within 3 months before surgery, or those with known drug abuse history; (6) Patients with severe cardiovascular or cerebrovascular diseases, as determined by the investigators, who are not suitable to participate in this study; (7) Patients with schizophrenia, severe depression, dementia or other mental or cognitive impairments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The visual analogue scale (VAS) for both resting and movement pain was evaluated before the operation;equivalent morphine consumption;Detect the levels of serum?Inter leukin-1ß?(IL-1ß), ?Interleukin-6(IL-6), tumor necrosis factor (TNF-a), C-reactive protein (CRP), and substance P.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Harris Hip Function score;Life quality score.;Pain-related side effects.;Safety of Fire Needling Treatment.;Patient satisfaction and blind assessment; | — |
Countries
China
Contacts
Wuhan Hankou Hospital, Wuhan City, Hubei Province